Low-level viremic persistence in suppressed ART-treated patients contributes to sustain the reservoir size and may occur upon standard antigen-specific responses to daily non-HIV related antigenic stimulation of latently infected CD4+ T cells [e.g.: vaccination, transient infections (38, 39)]. The gene discussed is CD4; the disease is infection.